Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
OTC Markets OTCPK - Delayed Quote USD

Paradigm Biopharmaceuticals Limited (PBIGF)

Compare
0.3807
0.0000
(0.00%)
At close: February 27 at 3:00:00 PM EST

Insider Purchases Last 6 Months

SharesTransactions
Purchases 0 0
Sales -- 0
Net Shares Purchased (Sold) 0 0
Total Insider Shares Held 43.12M --
% Net Shares Purchased (Sold) -- --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
Rennie (Paul) Managing Director -- Direct -- Nov 21, 2024
Rennie (Paul) Managing Director Purchase at price 0.14 per share. Direct 13,494 Oct 15, 2024
Fry (Matthew James) Director (Non-Executive) Purchase at price 0.14 per share. Direct 28,740 Oct 14, 2024
Fry (Matthew James) Director (Non-Executive) Purchase at price 0.14 per share. Direct 20,550 Oct 10, 2024
Rennie (Paul) Managing Director Purchase at price 0.14 per share. Direct 20,670 Oct 10, 2024
Fisher (Helen) Retired -- Direct -- Mar 4, 2024
Fry (Matthew James) Director (Non-Executive) -- Direct -- Mar 4, 2024
Fisher (Helen) Director (Non-Executive) Other at price 0.28 per share. Direct 289 Nov 30, 2023
Rennie (Paul) Managing Director -- Direct -- Nov 30, 2023
Rennie (Paul) Managing Director -- Direct -- Nov 30, 2023
Fisher (Helen) Director (Non-Executive) Purchase at price 0.65 per share. Direct 6,629 May 18, 2023
Rennie (Paul) Managing Director Purchase at price 0.68 per share. Direct 50,506 May 12, 2023
Waiting for permission
Allow microphone access to enable voice search

Try again.